INS and metabolic syndrome: The Aβ-degrading enzyme IDE preferentially binds insulin over Aβ and when insulin levels are high, as happens in the early stages of T2DM and MetS, the increased insulin results in competitive inhibition of Aβ binding and its degradation by IDE [157, 158].